Reserve your spot for the Certainty US 2026 customer event for exclusive access to the Certara community of experts, industry leaders, and peers as we collectively explore the latest innovations and opportunities to bring greater certainty to drug discovery and development.
April 14-15, 2026 | Boston, MA
Reserve your room here.
The QSP Summit is now a part of the Global Certainty customer event and will take place on day 2, April 15.
Based on attendee feedback, Certainty 2026 will feature more in-depth UGMs and Workshops on Pinnacle 21, QSP, Phoenix, Discovery, PK/PD, and PBPK. Choose the interactive sessions that best suit your interests over the 2-days:
P21 Live
On Day 1, follow the flow of data from protocol all the way to submission. On Day 2, we’ll look more closely at the Pinnacle 21 technology itself, from mapping specs and APIs to the progress of our solution for metadata management.
Phoenix UGM
On Day 1, explore how empirical PK/PD methods work alongside in silico approaches like PBPK and QSP to tackle development challenges. On Day 2, you’ll get an interactive look at new features, our roadmap, and AI’s expanding role in modeling and reporting.
QSP Summit
This dedicated Day 2 summit will explore how QSP is transforming MIDD through computational modeling, AI integration, and mechanistic insights. Sessions will feature case studies across disease areas, and forward-looking discussions on regulatory adoption and the future of predictive modeling.
Discovery UGM
With the explosion of new modalities, informatics is expanding its scope as AI closes gaps between chemistry, safety, and efficacy. Join this two-day track to explore how predictive modeling is reshaping compound design and enabling a clearer view downstream in drug discovery.
PBPK Modeling Workshop
This Day 2 exclusive session will showcase how PBPK informs decisions for first-in-human dosing to formulation, drug–drug interactions, and special population optimization. Expert talks and case studies will offer practical insights to strengthen confidence in model-informed development.
Modeling and Simulation from Strategy to Approval
On Day 1, learn how empirical PK/PD methods like NCA and popPK are complementing in silico approaches like PBPK and QSP to answer the most daunting challenges in development, from optimal first-in-human dosing to presenting clin pharm evidence effectively in your NDA or BLA.
Hear from attendees of the Certainty 2025 US event to learn more about what you can expect.
